Dec 08, 08
|
| NEW STORY |
| 08:00 ET |
Vion Pharmaceuticals Presents Additional Survival Data on Onrigin(TM) (Laromustine) Injection at ASH Annual Meeting
|
|
Nov 19, 08
|
| 08:00 ET |
Analyst Available to Comment on New JUPITER Study That Shows AstraZeneca's Crestor Significantly Reduces CV Risk
|
|
Nov 12, 08
|
| 10:00 ET |
Portola Announces Data Showing Its Anti-Platelet Drug Inhibits Platelets in Clopidogrel (Plavix(R)) Non-Responders
|
|
Nov 11, 08
|
| 10:30 ET |
Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation
|
|
Nov 10, 08
|
| 17:45 ET |
CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology(TM) Can Improve Cardiac Function
|
|
| 10:28 ET |
BSP Signs Agreement With CMP Trading for Distribution of HyperQ(TM) Stress System, for Early Detection of Ischemic Heart Disease, in South Korea
|
|
Nov 09, 08
|
| 19:04 ET |
VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
|
|
Nov 07, 08
|
| 08:00 ET |
Interim Analysis of Data from e-HEALING Registry of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at AHA Scientific Sessions 2008
|
|
Nov 06, 08
|
| 08:30 ET |
VIA Pharmaceuticals Announces Conference Call and Webcast to Discuss VIA-2291 Phase 2 Data Presentations at AHA
|
|
| 08:15 ET |
Atherotech to Exhibit VAP(R) Cholesterol Test at American Heart Association Scientific Sessions 2008
|
|
| 07:30 ET |
Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
|
|
Nov 05, 08
|
| 09:15 ET |
Corgenix to Exhibit AspirinWorks(R) Test, Discuss New CHARISMA Trial Results at AHA 2008 Meeting
|
|
Nov 03, 08
|
| 08:30 ET |
Top-Line Preliminary Data From Phase II/III Study of Corthera's Relaxin in Acute Heart Failure to be Presented in Satellite Symposium at AHA Scientific Sessions 2008
|
|